127 related articles for article (PubMed ID: 12819990)
1. Decreased estrogen receptor-alpha expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients.
Hu XY; Qin S; Lu YP; Ravid R; Swaab DF; Zhou JN
Acta Neuropathol; 2003 Sep; 106(3):213-20. PubMed ID: 12819990
[TBL] [Abstract][Full Text] [Related]
2. [Estrogen receptor alpha and colocalization of Bcl-2 in hippocampus of Alzheimer's disease].
Zeng M; Lu YP; Xu H; Zhou JN
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):108-11. PubMed ID: 15171543
[TBL] [Abstract][Full Text] [Related]
3. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
[TBL] [Abstract][Full Text] [Related]
4. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease.
Brady DR; Mufson EJ
J Comp Neurol; 1991 Mar; 305(3):489-507. PubMed ID: 2037717
[TBL] [Abstract][Full Text] [Related]
5. Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients.
Hu XY; Zhang HY; Qin S; Xu H; Swaab DF; Zhou JN
Exp Neurol; 2002 Nov; 178(1):104-11. PubMed ID: 12460612
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptors alpha and beta in choroid plexus epithelial cells in Alzheimer's disease.
Hong-Goka BC; Chang FL
Neurosci Lett; 2004 Apr; 360(3):113-6. PubMed ID: 15082146
[TBL] [Abstract][Full Text] [Related]
7. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
van de Nes JA; Konermann S; Nafe R; Swaab DF
Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
[TBL] [Abstract][Full Text] [Related]
8. Regional alteration of synapsin I in the hippocampal formation of Alzheimer's disease patients.
Qin S; Hu XY; Xu H; Zhou JN
Acta Neuropathol; 2004 Mar; 107(3):209-15. PubMed ID: 14673601
[TBL] [Abstract][Full Text] [Related]
9. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
[TBL] [Abstract][Full Text] [Related]
10. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease.
Attems J; Preusser M; Grosinger-Quass M; Wagner L; Lintner F; Jellinger K
Neuropathol Appl Neurobiol; 2008 Feb; 34(1):23-32. PubMed ID: 17961140
[TBL] [Abstract][Full Text] [Related]
11. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease.
Ishunina TA; Fischer DF; Swaab DF
Neurobiol Aging; 2007 Nov; 28(11):1670-81. PubMed ID: 17010478
[TBL] [Abstract][Full Text] [Related]
13. Changes in estrogen receptor-alpha and -beta in the infundibular nucleus of the human hypothalamus are related to the occurrence of Alzheimer's disease neuropathology.
Hestiantoro A; Swaab DF
J Clin Endocrinol Metab; 2004 Apr; 89(4):1912-25. PubMed ID: 15070964
[TBL] [Abstract][Full Text] [Related]
14. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
15. Alterations of hHrd1 expression are related to hyperphosphorylated tau in the hippocampus in Alzheimer's disease.
Hou HL; Shen YX; Zhu HY; Sun H; Yan XB; Fang H; Zhou JN
J Neurosci Res; 2006 Dec; 84(8):1862-70. PubMed ID: 17044033
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor alpha and beta immunoreactive neurons in normal adult and aged female rat hippocampus: a qualitative and quantitative study.
Mehra RD; Sharma K; Nyakas C; Vij U
Brain Res; 2005 Sep; 1056(1):22-35. PubMed ID: 16122717
[TBL] [Abstract][Full Text] [Related]
17. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease.
Good PF; Alapat D; Hsu A; Chu C; Perl D; Wen X; Burstein DE; Kohtz DS
J Neurochem; 2004 Nov; 91(3):716-36. PubMed ID: 15485501
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease.
Mizukami K; Ishikawa M; Iwakiri M; Ikonomovic MD; Dekosky ST; Kamma H; Asada T
Neurosci Lett; 2005 Sep; 386(2):111-5. PubMed ID: 15993539
[TBL] [Abstract][Full Text] [Related]
19. Colocalization and alteration of estrogen receptor-alpha and -beta in the hippocampus in Alzheimer's disease.
Lu YP; Zeng M; Swaab DF; Ravid R; Zhou JN
Hum Pathol; 2004 Mar; 35(3):275-80. PubMed ID: 15017582
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease.
Lee HG; Ogawa O; Zhu X; O'Neill MJ; Petersen RB; Castellani RJ; Ghanbari H; Perry G; Smith MA
Acta Neuropathol; 2004 Apr; 107(4):365-71. PubMed ID: 14872255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
